Introduction
============

Among the different types of cells present in the central (CNS) and peripheral (PNS) nervous systems, sensory neurons are of particular importance as they are continually relaying information about our environment. The trigeminal ganglion (TG) contains many of the sensory neurons innervating the head while the dorsal root ganglia (DRG) mostly innervate the rest of the body. Both groups are highly specialized pseudounipolar neurons that can detect and respond to a variety of chemical, mechanical, and thermal stimuli, serving as a warning system for mammals ([@B55]; [@B45]; [@B4]; [@B11]; [@B69]; [@B16]). TG neurons, in addition, have some distinct chemosensitive properties relating to olfaction and the gustatory system ([@B22]; [@B66]).

DRG and TG are formed by agglomerates of many thousands of primary afferent neurons. There is large heterogeneity, whereby different types of neurons have their own special perceptual modalities and therefore distinct cellular and molecular identities ([@B62]; [@B11]; [@B48]; [@B16]; [@B56]). Despite their functional similarities and capability to sense innocuous and noxious stimuli, DRG and TG neurons are very distinct in their location and connectivity. DRG afferents are found peripherally alongside the spinal cord and directly synapse onto spinal neurons, whereas TG neurons are localized at the base of the skull, projecting either directly to the brain stem or to the upper regions of the spinal cord ([@B4]; [@B20]). Moreover, DRG neurons derive from the neural crest, whereas TG neurons have dual origin, containing cells originated both from cranial neural crest and trigeminal ectodermal placodes ([@B2]; [@B7]; [@B17]; [@B20]; [@B37]). The distinction in cell fate at embryonic stages, together with some of the already mentioned exclusive functional characteristics and different connectivity patterns, suggests the existence of different molecular identities underlying either of these ganglia.

Studies have indeed started to characterize DRG and TG neurons at the molecular level using RNA sequencing (RNA-seq) ([@B47]; [@B5]; [@B53]; [@B63]; [@B21]; [@B58]; [@B30]; [@B60]; [@B70]; [@B36]) enabling in-depth analysis and characterization of their genome-wide transcriptional profiles. To date a few studies have reported approximately 200 differentially expressed genes in both rodents and humans ([@B47]; [@B21]; [@B36]). Among them were many odorant-binding proteins, ion channels, and G protein-coupled receptors ([@B47]; [@B21]). However, non-neuronal cells account for a significant proportion of cells in these ganglia ([@B11]; [@B26]; [@B17]; [@B31]) and therefore influence the transcripts present in these datasets, with neuronal genes underrepresented. Thus, a comparison in the expression profiles between enriched neuronal cell populations remains to be performed.

In this study, we examined lumbar DRG and TG ganglia with a specific focus on differences in neuronal gene expression. Using a combination of fluorescence-activated cell sorting (FACS), a transgenic mouse model and RNA-seq analysis, we identified a number of genes exclusively expressed in either DRG or TG neurons. Furthermore, we correlated our data with published studies and reveal that many genes previously believed to be present in neurons, are in fact either expressed in glial cells or other cell types. These findings are not only important for the understanding of the biology of primary afferents as whole, but could also aid development of drug treatments and gene therapies which seek unequivocal targets.

Results
=======

Isolation of Specific Populations of Neurons by FACS
----------------------------------------------------

We have previously demonstrated that conventional DRG dissociation results in a mixture of cells in which neurons only account for ∼10% of the population ([@B63]). In this study we used a sorting strategy, employing a mouse line expressing GFP under the control of the advillin promotor (Avil-GFP), which labels sensory neurons ([@B24]) (**Figure [1A](#F1){ref-type="fig"}** and Supplementary Figure [1](#SM4){ref-type="supplementary-material"}). Lumbar DRG and TG were dissociated, the cells were exposed to propidium iodide (PI) and isolated using FACS (**Figure [1B](#F1){ref-type="fig"}**; for gating strategies, please refer to section "Materials and Methods" and Supplementary Figure [2](#SM4){ref-type="supplementary-material"}). From all GFP+/PI- singlets, 500 events were captured for each biological replicate consisting of *n* = 6 mice for DRG and *n* = 4 mice for TG. Culture and analysis of sorted cells revealed that despite limited satellite glial cells, neurons accounted for over 70% of our isolated population (data not shown), a percentage we estimate to be slightly undervalued, given the proliferating nature of non-neuronal cells.

![Sensory neurons in the Avil-GFP transgenic mouse and schematic representation of neuronal isolation using flow cytometry. **(A)** Representative picture of DRG and TG ganglion showing the expression of EGFP under the control of the advillin promoter (green cells) in sensory neurons. Scale bar: 50 μm. **(B)** Lumbar DRG and TG were extracted from Avil-EGFP mice. Neurons were dissociated and exposed to propidium iodide (PI), and EGFP+ cells (neurons) were sorted using the gating strategy above, where the non-neuronal cells and PI+ cells were excluded (represented in the cartoon as gray and red). RNA was then extracted and sequenced.](fnmol-10-00304-g001){#F1}

RNA-Sequencing of DRG and TG Neurons
------------------------------------

Following the isolation of neurons by FACS, high-quality RNA was extracted (average RIN 8.75, min 7.6, max 9.9) and RNA-seq was performed on polyA+ mRNA using six DRG and four TG replicates. Between 20.7 and 30.3 million reads were uniquely aligned to the mm10 genome using STAR ([@B14]), corresponding to a median mapping percentage of 85.8%. Normalized gene expression values and differential gene expression were generated using the cufflinks and DESeq2 algorithms ([@B64]; [@B43]), respectively. Power calculations (using RNAPower; [@B27]) indicated that we were well-powered to detect twofold differences in gene expression (71% chance for all genes and 81--87% chance for the top 50% of all expressed genes).

A total of 12,638 genes were detected in either DRG or TG neurons (FPKM \> 1, in at least two of the replicates for each condition, Supplementary Table [1](#SM1){ref-type="supplementary-material"}). Our DRG and TG data were strongly correlated with the ranked expression profiles of pure DRG nociceptors ([@B63]): Spearman's rho *r*~s~ = 0.65, **Figure [2](#F2){ref-type="fig"}** and Supplementary Table [2](#SM2){ref-type="supplementary-material"}. Correlations are very sensitive to library batch effects and further depend on the number and expression levels of the gene sets included in the analysis. We therefore also conducted presence/absence calls, which again showed good overlap: 80% of the top 8000 genes were identified as present in both our current RNA-seq study and the DRG nociceptors dataset (Supplementary Table [2](#SM2){ref-type="supplementary-material"}).

![Expression profiles of mouse trigeminal neurons were well correlated with other, previously published datasets. Ranked FPKM values for mouse TG neurons obtained in this dataset are plotted against ranked FPKM values of three different comparison datasets: mouse DRG neurons obtained as part of this particular study (**A**, Spearman's *r*~s~ = 0.97), magnetically sorted DRG neurons obtained by [@B63] (**B**, Spearman's *r*~s~ = 0.64) and whole human TG data obtained by [@B21] (**C**, Spearman's *r*~s~ = 0.53). Solid lines indicate linear correlations. Note that within study correlations are necessarily higher than between study correlations due to the absence of technical batch effects stemming, e.g., from separate library preparation. See Supplementary Table [2](#SM2){ref-type="supplementary-material"} for the underlying data and for additional graphs of presence/absence calls.](fnmol-10-00304-g002){#F2}

Next, we looked for differences between our DRG and TG samples. DESeq2 analysis revealed 97 genes that were differentially expressed at adjusted *p*-value (adj. *p*) \< 0.05 (**Figures [3A,B](#F3){ref-type="fig"}**), which means that the great majority of genes (more than 99%) were commonly expressed. Of the genes which were different, 44 were upregulated in DRG neurons and 19 were upregulated in TG neurons, with 24 of the genes being present exclusively in either ganglia (**Table [1](#T1){ref-type="table"}**). Surprisingly, the vast majority of the latter were homeobox genes (Hox), accounting for ∼50% of the upregulated genes in the DRG (**Figure [3B](#F3){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**). Further to these neuronal genes, an additional 34 genes emerging from DESeq2 analysis were either not deemed to be expressed according to our FPKM expression cut-off or were not of unambiguously neuronal origin (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). The latter was determined by using a previously published RNA-seq dataset ([@B63]) in which DRG neurons were magnetically sorted, which prevents any contamination with satellite glial cells (see instruction sheet/tab of Supplementary Table [1](#SM1){ref-type="supplementary-material"} for further information).

![Differential expression of trigeminal versus dorsal root ganglion transcripts. **(A)** Volcano plot of differentially expressed genes obtained using *Deseq2*. Colored dots represent genes that were significantly dysregulated at FDR \< 0.05. Genes upregulated in trigeminal ganglion are depicted in light (log2FC \> 0) and dark blue (log2FC \> 1). Genes upregulated in dorsal root ganglion are depicted in light (log2FC \< 0) and dark pink (log2FC \< --1). Note that this graph includes genes which are not expressed according to our cut-off as well as those which are enriched in satellite glial cells (see Supplementary Table [1](#SM1){ref-type="supplementary-material"}). **(B)** The 44 unambiguously neuronal genes that were found to be upregulated in dorsal root ganglion at FDR \< 0.05 were fed into a protein--protein interaction analysis. The resulting network is depicted here and includes 28 genes, 50% of which were Hox genes.](fnmol-10-00304-g003){#F3}

###### 

Genes exclusively expressed in either ganglia, identified by RNA sequencing.

                                  Exclusive expression   
  -------------------- ---------- ---------------------- ---
  ENSMUSG00000020123   Avpr1a                            ✓
  ENSMUSG00000038112   AW551984   ✓                      
  ENSMUSG00000063415   Cyp26b1    ✓                      
  ENSMUSG00000029054   Gabrd                             ✓
  ENSMUSG00000078706   Gm53       ✓                      
  ENSMUSG00000043219   Hoxa6      ✓                      
  ENSMUSG00000038236   Hoxa7      ✓                      
  ENSMUSG00000038227   Hoxa9      ✓                      
  ENSMUSG00000000938   Hoxa10     ✓                      
  ENSMUSG00000048763   Hoxb3      ✓                      
  ENSMUSG00000038700   Hoxb5      ✓                      
  ENSMUSG00000000690   Hoxb6      ✓                      
  ENSMUSG00000038721   Hoxb7      ✓                      
  ENSMUSG00000001661   Hoxc6      ✓                      
  ENSMUSG00000001657   Hoxc8      ✓                      
  ENSMUSG00000036139   Hoxc9      ✓                      
  ENSMUSG00000022484   Hoxc10     ✓                      
  ENSMUSG00000027102   Hoxd8      ✓                      
  ENSMUSG00000043342   Hoxd9      ✓                      
  ENSMUSG00000050368   Hoxd10     ✓                      
  ENSMUSG00000028033   Kcnq5      ✓                      
  ENSMUSG00000049112   Oxtr                              ✓
  ENSMUSG00000005268   Prlr       ✓                      
  ENSMUSG00000026475   Rgsl6                             ✓

Table listing 24 genes which were exclusively present in the DRG (21 genes) and TG (three genes). First column shows the ENSEMBL Code ID for the gene; the second column lists the gene name and the third/fourth columns display the restrictive expression of the gene either in the DRG or TG (tick marks). Note that the vast majority of the genes are Hox genes. Differential expression was calculated using a Wald test with DESeq2. Exclusivity was considered when FPKM was ≥1 in one neuronal population and not present (FPKM \< 1) in the other population, and expression was not depleted in pure neurons (refer to Supplementary Table

1

for additional information)

.

Validation of Differentially Expressed Genes
--------------------------------------------

Given the identification of several differentially expressed genes between DRG and TG neurons in our dataset, we next went on to validate genes with potential functional relevance to pain states. Calcitonin gene-related peptide---CGRP (encoded by the gene CALCA)---is primarily expressed by sensory neurons and known to play a key role in inflammation and neuronal sensitization, particularly during nerve damage ([@B15]; [@B3]; [@B71]; [@B59]) as well as in migraine ([@B12]; [@B35]; [@B19]; [@B33]). Our transcriptome analysis revealed a large difference of approximately 2.5-fold increased expression of the CGRP gene in DRG in relation to TG neurons (AVRG FPKM DRG: 8216 and TG: 3430; adj. *p* \< 0.05; **Figure [4A](#F4){ref-type="fig"}**). To validate this finding we performed a CGRP ELISA from samples extracted from DRG and TG neurons. Results showed that whole DRG has significantly higher level of CGRP protein (**Figure [4B](#F4){ref-type="fig"}**); indeed, total CGRP levels were over threefold higher when compared to TG (*n* = 4/group; *p* \< 0.01; **Figure [4B](#F4){ref-type="fig"}**). We also carried out qPCR, where we showed a higher amount of CGRP mRNA in the DRG in an independent cohort of animals (*n* = 3 DRG; *n* = 4 TG; *p* = 0.056; **Figure [5A](#F5){ref-type="fig"}**).

![Validation of selected targets. **(A)** CGRP mRNA (Calca) was found to be significantly upregulated in our RNA-seq dataset. Plotted here are individual FPKM values, including means and standard errors of the means. **(B)** CGRP ELISA showed significantly increased protein levels in the DRG versus the TG of a separate cohort of mice: *n* = 4, independent samples *t*-test (two-tailed, heteroscedastic), *p* = 0.005.](fnmol-10-00304-g004){#F4}

![qPCR validation of differentially expressed genes. **(A)** Similarly to the RNA-seq dataset, CGRP mRNA (Calca) was higher in the DRG when compared to TG (^\#^*p* = 0.056). **(B)** Hoxa7 gene is exclusively expressed in DRG neurons (^∗∗∗^*p* \< 0.001), **(C)** whereas TrkA (Ntrk1) is equally expressed across the two groups of neurons (*p* \> 0.05). Results shown are from samples extracted from a separate cohort of mice: *n* = 3 DRG and *n* = 4 TG. Plotted here are individual ddCT values normalized to GAPDH, including means and standard errors of the means; *p*-values were obtained using a Mann--Whitney test.](fnmol-10-00304-g005){#F5}

In addition to CGRP, our RNA-seq data also show a differential expression of 15 Hox genes, all of which were exclusively expressed in DRG extracted from the lumbar region. To verify these findings, we performed qPCR in DRG and TG ganglia from a separate cohort of animals. Our results revealed Hoxa7 mRNA to be present only in lumbar DRGs but not in TG neurons (**Figure [5B](#F5){ref-type="fig"}**, n = 3 DRG; *n* = 4 TG; *p* \< 0.01). As a positive internal control, we probed for the Ntrk1 gene (TrkA) and, confirming our RNA-seq analysis, found no difference between the groups (**Figure [5C](#F5){ref-type="fig"}**).

Comparison between Mouse and Human Datasets
-------------------------------------------

Next, to characterize the similarity between the molecular profiles generated from mouse and human TG, we compared our data to the work of Flegel and collaborators ([@B21]). 12,317 genes were found to be expressed in either dataset, 90% of which were identified as equally present or absent in mouse and human (Supplementary Table [2](#SM2){ref-type="supplementary-material"}). Rank correlations were moderate (Spearman's rho *r*~s~ = 0.53, **Figure [2](#F2){ref-type="fig"}** and Supplementary Table [2](#SM2){ref-type="supplementary-material"}). Of the 63 differentially expressed neuronal genes identified in our rodent DRG--TG data, almost 70% followed the same trend toward up- or downregulation in the human data set (**Figure [6](#F6){ref-type="fig"}** and Supplementary Table [3](#SM3){ref-type="supplementary-material"}). Of the genes consistently regulated across species, 21 showed at least a twofold higher FPKM in human DRG compared to TG, while five showed a twofold increase in TG. Together, these analyses demonstrate the validity of our newly generated data and confirm the high molecular similarities between mouse and human sensory ganglia.

![Interspecies comparison of differentially expressed neuronal transcripts in mouse and whole ganglion transcripts in human. Of the 63 genes found to be differentially expressed in DRG and TG, 50 could also be easily identified in a dataset examining expression in human ([@B21]). Depicted here is a standardized heatmap of the average log2 (FPKM) values from the two different datasets. Blue indicates negative values, i.e., FPKM \< 1, with the genes likely lowly expressed or absent. Increasing levels of expression are represented by increasing degrees of red. See Supplementary Table [3](#SM3){ref-type="supplementary-material"} for the underlying raw FPKM values.](fnmol-10-00304-g006){#F6}

Discussion
==========

Our study is the first to provide a molecular profile of enriched TG and DRG neurons. Isolation of cells by FACS, followed by high throughput sequencing demonstrated key differences in expression level between neuron-specific genes in TG and DRG, among them ion channels as well as genes reportedly involved in pain processing. We validated our results in independent cohorts at message and protein level. Finally, we could demonstrate consistency between our newly generated RNA-seq and a previously published dataset examining whole human TG and DRG.

Studies to date have yielded significant insight into the cell biology of both TG and DRG, giving a clear idea of fiber demography, function, ratio, and distribution of myelinated and non-myelinated fibers in each of these ganglia, as well as how they contribute to nociception, pain, and migraine ([@B62]; [@B69]; [@B16]; [@B8]; [@B1]; [@B23]). However, relatively little is known about the molecular characteristics of these distinct neuronal populations, and how they compare at the transcriptional level. Our data revealed that, despite distinct embryogenic origin and processing capabilities, DRG and TG are surprisingly similar, with an almost identical molecular fingerprint. Nevertheless, we could identify 63 genes which were differentially expressed in these two primary neuron populations, including 24 genes that were found exclusively in either of the ganglia (**Table [1](#T1){ref-type="table"}**).

Our results are somewhat unexpected, especially when considering the highly specialized olfactory properties unique to the TG ganglia. Indeed, in a recent study, Manteniotis and collaborators identified almost 200 genes as differentially expressed between whole DRG and TG ([@B47]). The group described the presence of a number of TG-specific genes and hypothesized their involvement in olfactory processing ([@B47]). Our results, however, show that none of the genes listed by the authors---including Olfr420, Gm14744, and Lcn3---are expressed by isolated neurons. We believe the contrasting results might be due to tissue composition, given that the majority of cells after DRG dissociation are non-neuronal ([@B63]). This can lead to misinterpretation of RNA-seq data: neuron-specific genes could appear falsely downregulated if one type of ganglion were to contain a higher proportion of non-neuronal cells.

Similarly, differences in myelin composition or resident macrophage populations are visible and likely prominent in transcriptional datasets comparing whole DRG and TG. A good example is Kirrel2, which was initially described to be exclusively expressed in TG ganglia ([@B47]), but is in fact not present in pure TG neurons. Rather, it is highly expressed by astrocytes and oligodendrocytes ([@B72]), suggesting differential expression in the satellite glia or myelin of TG and DRG. Similarly, the calcium channels subunits Cacna1g and Cacna1s, which were proposed to be exclusively present in DRG ([@B47]), are in fact absent from DRG neurons, as shown by our data and previously published work ([@B63]; [@B65]). Instead, these genes are found to be expressed in other cells such as microglia and macrophages, both in the CNS and PNS ([@B25]; [@B40]; [@B72]; [@B9]), suggesting the non-neuronal origin of these transcripts. Notably, our results and analyses are not disputing the identity of genes previously reported as exclusive to the TG or DRG. We are only providing novel insight into which gene differences are likely to be of neuronal origin. In this context, it is also important to bear in mind that our dissociation method will favor medium and small diameter neurons over large diameter neurons (Supplementary Figure [3](#SM4){ref-type="supplementary-material"}). Indeed, genes like Hcn2 and Cacna2d4, which according to single cell data are likely to be exclusively expressed in large diameter DRG neurons ([@B65]; [@B41]), do not pass our FPKM expression cut-off.

The identification of differentially expressed genes allows for the manipulation and targeting of neuronal subpopulations. Here we show a remarkable difference in the expression of the CGRP gene (CALCA) in the two types of ganglia. CGRP is well known for its role as vasodilator and plays a central role in peripheral sensitization, hyperalgesia, and migraine ([@B3]; [@B59]; [@B33]; [@B61]). Our dataset confirms the presence of CGRP in both TG and DRG neurons, with the latter having over twofold higher expression of this gene---a result which is in line with RNA-seq data derived from human samples ([@B21]). These molecular data may seem counterintuitive at first glance. Migraine patients have elevated levels of CGRP ([@B35]; [@B19]; [@B33]), the reduction of which has repeatedly been shown to constitute a promising treatment avenue ([@B51]; [@B12]; [@B35]; [@B50]). In contrast, chronic pain conditions involving other areas of the body do not appear to be alleviated by modulation of CGRP ([@B61]). Yet, DRG appear to express much higher RNA message levels. The discrepancy becomes less jarring when one considers that nerve injury models which cause neuropathic pain conditions are commonly reported to cause downregulation of CGRP ([@B39]; [@B57]). This suggests that the gene may be implicated in divergent mechanistic processes in cranial versus peripheral pain conditions.

Another finding from our dataset is the differential regulation of the acid-sensing ion channel subtype-1 (ASIC1), which we identified to have higher expression in TG versus DRG neurons. In addition to having been implicated in neurite outgrowth, neuronal differentiation, synaptic plasticity, learning, memory as well as neuronal injury ([@B31]; [@B10]; [@B42]), ASIC1 has a well-documented link to mechanoreception, nociception, and pain ([@B10]; [@B52]). Previous studies also indicated that ASIC1 could be an analgesic target during pain states ([@B49]; [@B13]). Most notably, ASIC1 has recently been shown to be a new potential drug target for migraine ([@B29]; [@B18]). Our results are directly relevant to these findings, as we show that expression of the ASIC1 gene is notably higher in TG neurons when compared to DRG. Moreover, we newly identified ASIC1 as differentially expressed compared to previous datasets ([@B47]; [@B21]), likely because its presence in oligodendrocytes ([@B72]) would have obscured the neuron-specific difference in mixed tissues. This again highlights the importance of studying cell populations in isolation, as dilution effects can obscure crucial targets that might be used in clinic.

Besides genes linked to pain processing, our study also identified 15 Hox genes which are exclusively expressed in lumbar DRG neurons compared to TG. Hox genes are recognized for their key role as regulators of system development and cell fate specification during embryogenesis ([@B68]; [@B46]; [@B54]). Their continued presence in adult DRG is the most striking difference between the two types of ganglia: it can be detected at the level of whole TG and DRG ([@B47]; [@B21]; [@B36]), and similar anterior--posterior patterns are still discernible in adult CNS ([@B32]). In the brain, the expression of Hox genes after development has been linked to the regulation of key proteins that are involved in synapse formation and plasticity ([@B32]). Evidence is still sparse, but if it were to consolidate, Hox genes could represent an interesting exploratory drug target for some forms of chronic pain where changes in synaptic plasticity are well-recognized ([@B44]; [@B38]). The absence of Hox genes from the TG is likely due to the distinctive pattern of homeobox gene expression during development ([@B28]). We propose that, in the near future, these unique genes could also be used as "guides" in gene therapy, to either knockdown or overexpress genes in specific neurons during chronic pain states, as it has been proposed and already achieved in some specific cell types ([@B34]; [@B67]; [@B6]).

Unveiling the specific molecular identities of sensory neurons is crucial for understanding the biology of these highly specialized cells under healthy conditions as well as for developing effective therapies in disease. This is the first report of a molecular comparison between enriched DRG and TG neurons. Our RNA-seq analyses show that despite unexpected similarity, these two populations of neurons have some unique molecular characteristics, as evinced by 63 differentially expressed genes. We are confident that our results will benefit the scientific community by providing easily searchable, neuron-specific information on DRG and TG expression patterns. Furthermore, good agreement between mouse neurons and human tissue suggests that our analyses may aid in the continued quest for better drugs against chronic pain conditions, including migraine.

Materials and Methods {#s1}
=====================

Transgenic Mice
---------------

Avil-GFP mice \[see gensat.org: STOCK Tg (Avil-EGFP) QD84Gsat/Mmucd for BAC expression levels\] were bred in-house for several generations on a CD1 background. In all experiments, adult, age-matched (3--6 months) littermate controls from both genders were used. Mice were kept in a 12-h light--dark cycle, with food and water *ad libitum*. All experiments were performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and Local Ethical Committee approval.

Fluorescence-Activated Cell Sorting
-----------------------------------

Avil-GFP mice were deeply anesthetized with pentobarbital and transcardially perfused with 10 ml of PBS. TG (two ganglia/animal) or lumbar DRG (L1--L5, *n* = 10 lumbar ganglia/animal) were dissected out. Samples were then incubated in 3 mg/ml dispase, 0.1% collagenase and 200 U/ml DNase for 60 min at 37°C in a CO~2~ incubator, followed by gentle trituration in 1 ml of FACS buffer (5% trehalose, 0.05 mM APV, 15 mM HEPES in DPBS). PI (2.5 μg/ml) was added to the cell suspension so dead cells could be identified during sorting.

Following dissociation, neuronal cell isolation was performed using a BD FACS Aria II Cell Sorter at the NIHR BRC flow core facility at King's College London (nozzle size 100 μM). Cell populations were gated on GFP+, PI- signal with the help of unstained and single-staining controls. For every experiment, cells from a non-transgenic control animal were used for compensation controls. Positive events (500/animal) were sorted directly into Qiagen RLT buffer and beta-mercaptoethanol and stored at -80°C until the entirety of the biological samples were collected and processed for RNA extraction using a RNeasy Micro kit (Qiagen) with minor modifications of the manufacturer's protocol. Sample quality was confirmed on an Agilent Bioanalyzer (average RIN value of 8.75, min 7.6, max 9.9).

Sequencing
----------

RNA-seq was performed as previously described ([@B63]). In brief, samples were sent for batch-controlled library preparation (SMARTer Ultra Low Input HV kit, 634820, Clontech) and sequencing at the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics at Oxford University. Following amplification, samples were multiplexed in replicate flow cells on an Illumina HiSeq 4000 platform. Reads were uniquely aligned to the mm10 genome using STAR ([@B14]), yielding a median mapping percentage of 85.8% (min 80.7%, max 87.6%, standard mapping parameters, bar---outFilterMultimapNmax 1). Normalized gene expression values and differential gene expression data were generated using the cufflinks and DESeq2 algorithms ([@B64]; [@B43]), respectively. We applied an FPKM expression cut-off, based on the underlying distribution of our cufflinks data: FPKM ≥ 1 in at least two of the replicates for each condition. Please note that expression cut-offs will be specific to each individual RNA-seq dataset (as FPKM values are modeled on a curve) and are necessarily somewhat arbitrary. Ours is quite liberal and will likely overestimate the presence of particular gene transcripts. Raw and processed data are available under GEO accession GSE100175.

ELISA
-----

CGRP (Calca) protein levels were measured from freshly extracted DRG and TG samples using a CGRP ELISA kit according to manufacturer's instructions (Bertin Pharma, 589001). Briefly, the tissue was macerated with a hand-held homogenizer in 200 μl EIA buffer, and the resultant protein was bound by anti-CGRP antibody for 5 min at room temperature. Samples were washed five times and the signal developed with Ellman's reagent and read on an ELISA plate reader (Molecular Devices, 410 nM). All samples, standards and negative controls were processed in duplicate. The resulting standard curve was linear as required (*y* = 0.004*x* + 0.0973, *R*^2^ = 0.98), and all samples fell within the limits of the standard samples.

qRT-PCR
-------

Animals were deeply anesthetized with pentobarbital and transcardially perfused with PBS. DRG (lumbar, L3--L6) and TG were collected and RNA was prepared with the RNeasy Micro kit (Qiagen). Total RNA (500 μg) was converted to cDNA using the SuperScript^®^ III Reverse Transcriptase kit (Thermo Fisher Scientific). Quantitative real-time PCR (qPCR) was performed in duplicate with a SYBR green master mix (Roche Diagnostics Limited) with the addition of the selected gene primer sequences (Sigma)---see below. ΔCts were calculated in relation to a house keeping gene (GAPDH). In all experiments, qPCR reactions were run in a Roche Lightcycler 480 PCR machine. Results were analyzed by the standard ΔΔCt method. All primers were checked for their efficiency and specificity beforehand.

> Cgrp_F: CTGAGGGCTCTAGCTTGGAC;

> Cgrp_R: TGCCAAAATGGGATTGGTGG

> Hoxa7_F: CAGTTTCCGCATCTACCCCT;

> Hoxa7_R: CGTCTGGTAGCGCGTGT

> TrkA_F: GAAGAATGTGACGTGCTGGG;

> TrkA_R: GAAGGAGACGCTGACTTGGA

> Gapdh_F: GGTCCCAGCTTAGGTTCATCA;

> Gapdh_R: CCAATACGGCCAAATCCGTTC

Imaging
-------

Avil-GFP mice were deeply anesthetized with pentobarbital and transcardially perfused with PBS followed by a 4% PFA solution. Tissue was dissected out (DRG and TG), post fixed for 2 h and placed in 30% sucrose solution and left overnight at 4°C. Samples were then embedded in OCT and cut on a cryostat (10 μm sections). Slides were incubated with blocking buffer (10% donkey serum, 0.02% Triton X-100 in PBS), for ∼6 h at room temperature. Sections were then incubated with anti-NeuN antibody (1:1000; Rabbit---Millipore) overnight at room temperature. Primary antibody was removed by washing with PBS, three times. Secondary antibody conjugated with Alexa 594 (Invitrogen) was diluted in the blocking buffer (1:1000), and slides were incubated for at least 2 h at room temperature. Slides were then mounted using Fluoromount-G^®^ medium (Southern Biotechnology) and allowed to dry for 48 h. Endogenous EGFP alongside with Alexa 594 from the sections were imaged using the tile imaging mode (mosaic function) in a Zeiss 710 LSM Axio Imager.Z2 Microscope, at 20×/0.8 DICII magnification. Images were processed (stitched and scale bars placed) using the Zen 2012---Blue Edition software (Zeiss).

Statistics
----------

For all the validation experiments, normality was confirmed by Shapiro--Wilk test. If samples showed a normal distribution, parametric tests were used, otherwise, samples were analyzed by a non-parametric test.

For the CGRP ELISA assay experiments, an independent samples *t*-test (two-tailed, heteroscedastic) was used. For the qPCR experiments, a Mann--Whitney non-parametric test was performed.

Statistical analyses were performed using Prism 5 software or SPSS.
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Avil

:   advillin

AVRG

:   average

CGRP

:   calcitonin gene-related peptide

DRG

:   dorsal root ganglia

FACS

:   fluorescence-activated cell sorting

FPKM

:   Fragments Per Kilobase of transcript per Million mapped reads

GFP or EGFP

:   (enhanced) green fluorescent protein

Hox

:   homeobox

mRNA

:   messenger RNA

PI

:   propidium iodide

qPCR

:   quantitative polymerase chain reaction

RIN

:   RNA integrity number

RNA

:   ribonucleic acid

RNA-seq

:   RNA sequencing

TG

:   trigeminal ganglia.
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